FDA Drug Recalls

Recalls / Class II

Class IID-0817-2018

Product

Hydrocortisone Ointment, USP 2.5%, Net Wt. 20g, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed by Perrigo, Allegan MI 49010, NDC 45802-014-02

Brand name
Hydrocortisone
Generic name
Hydrocortisone
Active ingredient
Hydrocortisone
Route
Topical
NDCs
45802-004, 45802-014
FDA application
ANDA085025
Affected lot / code info
Lot Numbers: 7AT0283V, exp. 11/18 7AT0284V, exp. 11/18 7AT0285V, exp. 11/18 7FT0460, exp. 05/19 7FT0461, exp. 05/19 7GT0465, exp. 06/19 7GT0466, exp. 06/19 7JT0390, exp. 08/19 7JT0392, exp. 08/19 7KT0588, exp. 09/19 7KT0589, exp. 09/19

Why it was recalled

Failed Stability Specifications

Recalling firm

Firm
Perrigo New York
Manufacturer
Padagis Israel Pharmaceuticals Ltd
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1700 Bathgate Ave, Bronx, New York 10457-7512

Distribution

Quantity
571,632 tubes
Distribution pattern
US Nationwide including Puerto Rico.

Timeline

Recall initiated
2018-05-07
FDA classified
2018-05-16
Posted by FDA
2018-05-23
Terminated
2018-12-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0817-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.